Neil Lerner, CHIEF ACCOUNTING OFFICER at Compass Therapeutics, Inc., Buys Shares Worth $2,850

Compass Therapeutics, Inc. (CMPX) disclosed that Neil Lerner, who holds the position of CHIEF ACCOUNTING OFFICER at the company, was involved in buying 2,500 shares, per a Form 4 filing with the SEC.

The transaction was executed at a price of $1.14 per share, for a total value of approximately $2,850.

Company insiders are required to disclose changes in their stock ownership to the SEC on Form 4, typically within two business days of the trade.

Insider buying is sometimes viewed by investors as a signal of confidence in a company's prospects, though a single transaction does not necessarily indicate a broader trend.